ENvue Medical Shares Plunge 23% on Nasdaq Delisting Notice

Key Facts

1ENvue Medical shares fell 23% in after-hours trading following a Nasdaq decision to delist the company.

2ENvue Medical is preparing to transition its share trading to the OTC Markets following its exit from Nasdaq.

In a move reflecting the operational challenges facing micro-cap companies, ENvue Medical shares plummeted 23% in after-hours trading. This sharp decline followed an official notice that the company will be delisted from the Nasdaq exchange. According to reports, the decision prompted investors to liquidate positions ahead of the stock's migration to alternative trading platforms.

The company is currently preparing to transition its share trading to the OTC Markets following its exit from Nasdaq. Delisting from major exchanges typically results in reduced liquidity and diminished institutional investor confidence. Per market data, FEED stock closed at $1.03 on September 15, 2026, having experienced significant volatility with a daily range between $0.84 and $3.42.

Traders should monitor support levels near the recent low of $0.84 (close of September 15, 2026) as the transition to OTC markets begins. Looking at the economic calendar, there are no immediate forward catalysts for the company, though broader market sentiment remains sensitive to global inflation data scheduled for the coming days.